Bafilomycin A1 - Endosomal Acidification Inhibitor

InvitroFit™ Autophagy modulator

ABOUT

Endosomal acidification and autophagy inhibitor

Bafilomycin A1 (BafA1), a macrolide antibiotic isolated from Streptomyces species, is a specific vacuolar H+ ATPase (V-ATPase) inhibitor. Notably, due to its ability to specifically target V-ATPase and hence disrupt autophagic flux, BafA1 is frequently used to study autophagy and endosomal acidification. Autophagy is one of the three principal mechanisms used by cells to sequester, remove and recycle waste, the others being proteasomal degradation and phagocytosis. BafA1 suppresses the growth of a variety of cancer cells by inhibiting autophagy and inducing apoptotic cell death via various mechanisms [1, 2]. Inhibition of autophagy by BafA1, in combination with anti-cancer therapies (e.g. chemotherapy), represents a promising therapeutic approach that is currently being tested in clinical trials [1].

More details

 

Mode of action:

By inhibiting V-ATPase, BafA1 prevents the maturation of autophagic vacuoles by inhibiting late-stage fusion between autophagosomes and lysosomes as well as lysosomal degradation [3]. V-ATPases establish and maintain a low luminal pH in endocytic and exocytic compartments. Upon binding to the V-ATPase complex BafA1 inhibits H+ translocation, thereby depriving acidic intracellular compartments (i.e. endosomes, lysosomes, and vesicles) of H+ ions, increasing their pH and inhibiting the function of resident hydrolases. On the other hand, this causes an accumulation of H+ in the cytoplasm of treated cells, leading to acidosis and thus, can cause secondary adverse effects in normal cells [1].

 

Key features:

  • Specific and potent V-ATPase inhibitor frequently used to study autophagy
  • InvitroFit™ grade: highly pure (> 90%) and inhibitory function validated in cellular assays

 

Read our review Read our review on Autophagy and Innate Immunity

 

References

1. Yan, Y. et al. 2016. Bafilomycin A1 induces caspase-independent cell death in hepatocellular carcinoma cells via targeting of autophagy and MAPK pathways. Sci Rep 6, 37052.
2. Yuan, N. et al. 2015. Bafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemia. Haematologica 100, 345-356.
3. Yamamoto, A. et al. 1998. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct 23, 33-42. 

All InvivoGen products are for internal research use only, and not for human or veterinary use.

InvitroFit™

InvitroFit™ is a high-quality standard specifically adapted for in vitro studies of inhibitors. InvitroFit™ products are highly pure (≥95%) and guaranteed free of bacterial contamination, as confirmed using HEK Blue™ TLR2 and HEK Blue™ TLR4 cellular assays. Each lot is rigorously tested for functional activity using validated (or proprietary) cellular models. This grade ensures reliability and reproducibility for your research applications.

SPECIFICATIONS

Specifications

Species
Streptomyces sp.
CAS number
88899-55-2
Chemical formula

C35H58O9

Molecular weight
622.83 g/mol
Purity
≥ 90% (HPLC)
Solubility

0.1 mg/ml in DMSO or ethanol

Appearance (form)
Translucent film
Appearance (color)
Colorless
Working concentration

0.1 - 1 μM

Endotoxin

Negative (tested using EndotoxDetect™ assay)

Tested applications

In vitro cellular assays

Quality control

Each lot is functionally tested and validated using cellular assays.

CONTENTS

Contents

  • Product: 
    Bafilomycin A1
  • Cat code: 
    tlrl-baf1
  • Quantity: 
    10 µg
Notes:

Bafilomycin is provided as a translucent film.

Shipping & Storage

  • Shipping method:  Room temperature
  • Storage:

    • -20°C
    Stability: The reconstituted product is stable up to 6 months at -20 °C.

    Caution:

    • Avoid repeated freeze-thaw cycles

Details

Autophagy:

Autophagy is an orchestrated homeostatic process to eliminate unwanted proteins and damaged organelles [1-3]. The autophagic process is also used to remove intracellular microbial pathogens. Several signaling pathways sense different types of cell stress, ranging from nutrient deprivation to microbial invasion, and converge to regulate autophagy at multiple stages of the process.
mTOR is a major negative regulatory axis of autophagy. Direct inhibitors of mTOR and those of pathways activating mTOR, subsequently induce autophagy [4].
In addition, Beclin1 is negatively regulated by caspases, the inhibitors of which act to promote Beclin1 action to induce the initial stages of autophagy.
Furthermore, inhibitors of the 26S proteasome and the epigenetic regulators, histone deacetylases and DNMTs, result in the increase of Atg and LC3 protein levels essential to the process of autophagy.

 

References

1. Levine B. & Kroemer G., 2008. Autophagy in the pathogenesis of disease. Cell. 132(1):27-42.
2. Mizushima N. et al., 2008. Autophagy fights disease through cellular self-digestion. Nature. 451(7182):1069-75.
3. Netea-Maier et al., 2016, Modulation of inflammation by autophagy: Consequences for human disease. Autophagy. 12(2): 245–260.
 4. Jung CH. et al., 2010. mTOR regulation of autophagy. FEBS Lett. 584(7):1287-95. 

 

Chemical structure of Bafilomycin A1

Chemical structure Bafilomycin A1

DOCUMENTS

Documents

Bafilomycin A1

Technical Data Sheet

Safety Data Sheet

Validation Data Sheet

Certificate of analysis

Need a CoA ?

CUSTOMER SERVICE & TECHNICAL SUPPORT

Question about this product ?